Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04483739
Title Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL) (IsKia)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors European Myeloma Network
Indications

multiple myeloma

Therapies

Carfilzomib + Dexamethasone + Lenalidomide

Carfilzomib + Dexamethasone + Isatuximab + Lenalidomide

Age Groups: adult | senior
Covered Countries


No variant requirements are available.